$LRSV -Link Reservations Inc./LinkResPet (LRSV) CB
Post# of 6702
*Great news out yesterday. LRSV had largest wholesale purchase yr to date
Thu, May 13, 2021, 9:51 AM
London, United Kingdom--(Newsfile Corp. - May 13, 2021) - Link Reservations Inc. (OTC Pink: LRSV) (the "Company" , a provider of mushroom and cannabidiol (CBD) wellness products for both humans and pets, is pleased to announce that its CBD product for dogs is now re-stocked and available again for retail and wholesale purchase.
Rene Lauritsen, CEO of Link Reservations Inc, commented: "These are exciting times. CBD products are increasingly becoming staple wellness options for pet owners and demand continues to be high, which is great! We will keep developing new products and have several new projects on the table."
In the past weeks, LRSV has also recorded its largest single purchase of its pet CBD products to date, poising the Company for its best sales year yet.
"As we continue to explore further wholesale and retail opportunities, we are expecting to start increasing our revenue sources and build on this success. LinkResPet.com and its sister site DailyLifeCBD.com are both expecting exciting developments and will update shareholders and the investment community upon fruition," he added.
For more information about LinkResPet or to purchase CBD products for pets, please visit www.linkrespet.com or follow us on Twitter: @res_pet.
For more information about DailyLifeCBD, the Company's range of CBD and mushroom product for people, please visit to learn more or purchase: https://dailylifecbd.com/.
About Link Reservations Inc.
Link Reservations Inc is a CBD and wellness product provider dedicated to improving the health and life conditions of both people and pets worldwide. Its trades through its two brands; LinkResPet and DailyLifeCBD. LinkResPet develops and markets hemp-based CBD products for cats, dogs and horses. DailyLifeCBD provides everyday hemp based CBD wellness & Mushroom products for people. The Company has operations in both the US and Europe.